Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Cardiovascular and Circulatory System – Ischemia Contains Detailed Information on the Current Drug Pipeline

July 17, 2008

Research and Markets (http://www.researchandmarkets.com/research/84a9c3/cardiovascular_and) has announced the addition of the “Cardiovascular and Circulatory System – Ischemia” report to their offering.

“Cardiovascular and Circulatory System Ischemia” contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

— Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.

— Keep track of your competitors and partners by better understanding their product pipeline.

— Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.

— Maintain a critical competitive advantage.

 Key Topics Covered:  Ischemia Pipeline Overview --% of Projects (By Phase of Development) --No. of Projects by Phase of Development --Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects --Company Overview - Pipeline Projects  --Top Companies in late stage Ischemia Projects --DNAVEC Corporation --t2cure GmbH  --Top Companies in early stage Ischemia Projects --BioCardia, Inc. --AnGes MG, Inc. --Biopure Corporation --Biomedica foscama --DAIICHI SANKYO COMPANY, LIMITED --CardioVascular BioTherapeutics Inc --Panacea Pharmaceuticals, Inc. --KAI Pharmaceuticals Inc. --Sangamo BioSciences Inc --Pierre Fabre Medicament --Vascular Biogenics Ltd. --t2cure GmbH --ViroMed Co., Ltd --VasoGenix Pharmaceuticals, Inc.  Pipeline Revenue --Pipeline Revenue Full Pipeline View --Pre Clinical Pipeline View --Phase I Pipeline View --Phase II Pipeline View --On the Market Pipeline View --Discovery/Development Pipeline View 

For more information visit http://www.researchandmarkets.com/research/84a9c3/cardiovascular_and

Source: Life Science Analytics